apples posted this in another SIP thread, but it looks like a capital return will be happening:
http://www.businessspectator.com.au/bs.nsf/Article/Sigma-pharmaceuticals-Mark-Hooper-Aspen-health-pd20100816-8D3XQ?opendocument&src=rss
"Sigma has on-balance-sheet debt of about $450 million and therefore the capacity to either fund sensible expansion of the healthcare business or, as Jamieson suggested today, return some capital to its shareholders."
If the Chairman suggests it, it will happen! Now, anyone got any guesses as to if the capital return will take us up to the 55c offer that Aspen made? Certainly, the SP will rise on the possibility of a capital return. It could be a clean exit opportunity.
Add to My Watchlist
What is My Watchlist?